Profile data is unavailable for this security.
Mergers & acquisitions
Acquired company | AZN:LSE since announced | Transaction value |
---|---|---|
Fusion Pharmaceuticals Inc | 19.71% | 2.30bn |
Amolyt Pharma SAS | 17.79% | 1.05bn |
Gracell Biotechnologies Inc | 18.03% | 1.10bn |
Icosavax Inc | 22.01% | 862.87m |
Data delayed at least 20 minutes, as of May 13 2024 13:14 BST.
Holder | Shares | % Held |
---|---|---|
Da Cheng Fund Management Co., Ltd.as of 30 Jun 2023 | 0.00 | 0.00% |
Data from 30 Jun 2023 - 30 Jun 2023Source: FactSet Research Systems Inc.